Santen Pharmaceutical Co., Ltd. held its 99th Annual General Meeting of Shareholders for the fiscal year 2010 on June 22
, 2011. The Meeting started at 10:00 a.m. and ended at 10:59 a.m. The number of shareholders attended was 180.
Matters reported:
| 1. |
Business Report, Consolidated Financial Statements and Non-consolidated Financial Statements for the 99th Business Term (April 1, 2010 to March 31, 2011) |
| 2. |
Independent Auditors Report and Corporate Auditors Report on the consolidated Financial Statements for the 99th Business Term ( April 1, 2010 to March 31, 2011) |
Questions:
Question regarding medium-term management plan, sales performance by business segment, sales impact by generic drug, status of new product pipeline, return policy to shareholders were answered.
Matters resolved:
Six items of business as described below were all resolved.
Resolution [PDF:23KB]
Questions:
There was no question submitted by shareholders.
Back to top |
|
|
